The research report should be a detailed narrative explaining the function, biological processes, and localization of the gene product. Citations should be given for all claims.
You should prioritize authoritative reviews and primary scientific literature when conducting research. You can supplement
this with annotations you find in gene/protein databases, but these can be outdated or inaccurate.
We are specifically interested in the primary function of the gene - for enzymes, what reaction is catalyzed, and what is the substrate specificity? For transporters, what is the substrate? For structural proteins or adapters, what is the broader structural role? For signaling molecules, what is the role in the pathway.
We are interested in where in or outside the cell the gene product carries out its function.
We are also interested in the signaling or biochemical pathways in which the gene functions. We are less interested in broad pleiotropic effects, except where these elucidate the precise role.
Include evidence where possible. We are interested in both experimental evidence as well as inference from structure, evolution, or bioinformatic analysis. Precise studies should be prioritized over high-throughput, where available.
The human ERP29 gene (chromosome 12, UniProt accession P30040) encodes endoplasmic reticulum resident protein 29 (ERp29), also known as ERp28, ERp31, or PDIA9 (rahman2022functionsandmechanisms pages 1-2, sakono2022erendogenousprotein pages 2-4). ERp29 is classified as a noncanonical member of the protein disulfide isomerase (PDI) family, distinguished by its lack of traditional oxidoreductase activity (powell2021proteindisulphideisomerase pages 3-4, rahman2022functionsandmechanisms pages 1-2). This 29 kDa protein is ubiquitously expressed across tissues and cell types, with particularly high abundance in secretory epithelia (huang2015erp29attenuatescigarette pages 1-2, bikard2019thekdelreceptor pages 1-2).
| Category | ERp29 summary | Evidence |
|---|---|---|
| Protein identity and synonyms | Human ERP29 encodes endoplasmic reticulum resident protein 29; reported aliases include ERp29, ERp28, ERp31, and PDIA9. It is treated in the literature as a noncanonical member of the PDI family. | (rahman2022functionsandmechanisms pages 1-2, sakono2022erendogenousprotein pages 2-4) |
| Domain architecture | ERp29 contains an N-terminal thioredoxin-like domain and a C-terminal D domain unique to ERp29; the D domain is the principal interface for binding lectin chaperones in the calnexin/calreticulin system. | (kozlov2017mappingtheer pages 1-3, kozlov2017mappingtheer pages 4-5) |
| Key structural features | Unlike classical PDI enzymes, ERp29 lacks a functional CXXC active-site motif and is therefore not considered a typical oxidoreductase; one study/reviewed summary notes a single cysteine (Cys157) instead. ERp29 also carries a C-terminal KEEL ER-retention motif, a KDEL-like sequence linked to relatively weak ER retention and recycling through the early secretory pathway. | (bikard2019thekdelreceptor pages 1-2, sakono2022erendogenousprotein pages 2-4) |
| Oligomeric/structural behavior | ERp29 is described as a dimer whose N-terminal thioredoxin-like region mediates homodimerization, while the D domain forms the binding surface for partner chaperones. Structural work identified helices α8/α9 and residues including R223, L227, L241 as critical for P-domain binding. | (kozlov2017mappingtheer pages 1-3, kozlov2017mappingtheer pages 4-5, kozlov2017mappingtheer pages 5-6) |
| Primary molecular function | ERp29 functions primarily as an ER luminal chaperone/co-chaperone that assists folding, maturation, and trafficking of secretory and membrane proteins. Its role is best understood as general protein-folding assistance rather than catalysis of disulfide exchange. | (huang2015erp29attenuatescigarette pages 1-2, adams2021theroleof pages 1-3, sakono2022erendogenousprotein pages 2-4) |
| Role in calnexin/calreticulin cycle | In the calnexin/calreticulin cycle, ERp29 is recruited by the P domains of calnexin (CNX) and calreticulin (CRT) as a function-specific chaperone, alongside ERp57 and cyclophilin B, to help mature monoglucosylated glycoprotein clients. | (kozlov2017mappingtheer pages 1-3, kozlov2020calnexincycle– pages 1-3, sakono2022erendogenousprotein pages 2-4) |
| Binding affinity data | The ERp29 D domain binds CNX/CRT P domains with micromolar affinity; reported values are better than 20 μM by NMR for CNX and about 13 μM for full-length ERp29–CRT by surface plasmon resonance. | (kozlov2017mappingtheer pages 3-4, kozlov2017mappingtheer pages 4-5) |
| Known substrates / client classes | Experimentally implicated clients include thyroglobulin (folding/secretion), collagen, ENaC during channel biogenesis, and broader classes of glycoproteins handled through the calnexin/calreticulin pathway. | (kozlov2017mappingtheer pages 1-3, kozlov2020calnexincycle– pages 1-3, bikard2019thekdelreceptor pages 1-2, baryshev2004unfoldedproteinresponse pages 1-2) |
| Thyroglobulin-related role | ERp29 associates with thyroglobulin (Tg) in congenital hypothyroid disorders featuring ER-retained mutant Tg, supporting a role in Tg quality control and secretion. | (baryshev2004unfoldedproteinresponse pages 1-2) |
| ENaC-related role | ERp29 regulates epithelial sodium channel (ENaC) biogenesis; its KEEL motif and interaction with the KDEL receptor (KDEL-R) influence forward trafficking/processing during passage through the early secretory pathway. | (bikard2019thekdelreceptor pages 1-2) |
| Binding partners | Reported interacting or functionally associated partners include calnexin, calreticulin, ERp57, cyclophilin B (CypB), KDEL receptor, and stress/folding chaperones such as BiP/GRP78 and GRP94. | (kozlov2017mappingtheer pages 1-3, huang2015erp29attenuatescigarette pages 1-2, kozlov2020calnexincycle– pages 1-3, bikard2019thekdelreceptor pages 1-2) |
| Subcellular localization | ERp29 is primarily an ER lumen resident protein. Because its KEEL motif is a weaker KDEL variant, it can function dynamically in the early secretory pathway, including ER-to-Golgi trafficking steps and likely ERGIC/proximal Golgi recycling behavior. | (huang2015erp29attenuatescigarette pages 1-2, bikard2019thekdelreceptor pages 1-2, sakono2022erendogenousprotein pages 2-4) |
| Associated pathways | Main pathways/processes linked to ERp29 are the calnexin/calreticulin cycle, ER protein folding/quality control, unfolded protein response (UPR)/ER stress adaptation, ER-associated degradation (ERAD)-linked quality control, and protein secretion/ER-to-Golgi trafficking. | (kozlov2020calnexincycle– pages 1-3, suzuki2021foldingandquality pages 1-3, baryshev2004unfoldedproteinresponse pages 1-2) |
| ER stress biology | ERp29 is stress responsive and can modulate ER-stress outputs: in RPE cells, ERp29 overexpression increased GRP78, p58IPK, and Nrf2, while reducing p-eIF2α and CHOP, consistent with a protective role during ER stress. | (huang2015erp29attenuatescigarette pages 1-2) |
| Current functional interpretation | Overall, ERp29 is best understood as a specialized, noncatalytic PDI-family chaperone that couples client folding to lectin-chaperone recruitment and early secretory-pathway trafficking, rather than as a classical disulfide isomerase enzyme. | (kozlov2017mappingtheer pages 1-3, adams2021theroleof pages 1-3, rahman2022functionsandmechanisms pages 1-2, kozlov2020calnexincycle– pages 1-3) |
Table: This table summarizes the main structural features, molecular functions, interaction partners, substrates, localization, and pathway context of human ERp29. It is useful as a compact evidence-based reference for functional annotation of ERP29.
ERp29 possesses a distinctive bi-domain architecture comprising an N-terminal thioredoxin-like domain and a C-terminal D domain (kozlov2017mappingtheer pages 1-3, kozlov2017mappingtheer pages 4-5). Unlike classical PDI family members, ERp29 lacks the characteristic CXXC catalytic motif essential for disulfide bond formation and isomerization, containing instead only a single cysteine residue at position 157 (bikard2019thekdelreceptor pages 1-2, sakono2022erendogenousprotein pages 2-4). This structural feature fundamentally distinguishes ERp29 from oxidoreductase PDIs, establishing its primary role as a chaperone rather than a catalyst (adams2021theroleof pages 1-3, rahman2022functionsandmechanisms pages 1-2).
The N-terminal thioredoxin-like domain mediates homodimerization and binds denatured protein substrates, while the unique C-terminal D domain serves as the principal binding interface for lectin chaperones in the calnexin/calreticulin system (kozlov2017mappingtheer pages 1-3, kozlov2017mappingtheer pages 4-5). Crystal structures of the ERp29 D domain in complex with P domains from calreticulin (PDB: 5V8Z) and calmegin (PDB: 5V90) reveal that the D domain adopts an all-helical fold with two C-terminal antiparallel helices (α8 and α9) extending from a three-helix bundle (kozlov2017mappingtheer pages 3-4, kozlov2017mappingtheer pages 4-5). Key residues including R223, L227, and L241 within the D domain are critical for P-domain binding through a combination of salt bridges, hydrogen bonds, and hydrophobic interactions (kozlov2017mappingtheer pages 4-5, kozlov2017mappingtheer pages 5-6).
ERp29 functions primarily as an endoplasmic reticulum (ER) luminal resident protein, as determined by its C-terminal KEEL retention motif—a variant of the canonical KDEL sequence (bikard2019thekdelreceptor pages 1-2, sakono2022erendogenousprotein pages 2-4). The KEEL motif provides less robust ER retention compared to KDEL, enabling dynamic cycling between the ER and Golgi apparatus via interactions with the KDEL receptor (KDEL-R) (bikard2019thekdelreceptor pages 1-2). This weaker retention mechanism allows ERp29 to escort client proteins through the early secretory pathway, including the ER-Golgi intermediate compartment (ERGIC), facilitating both protein folding assistance and quality control during trafficking (huang2015erp29attenuatescigarette pages 1-2, bikard2019thekdelreceptor pages 1-2). Bikard et al. (2019) demonstrated that the KDEL-R plays an essential role in ERp29-mediated regulation of protein biogenesis and forward trafficking, supporting a model where ERp29 dynamically associates with the ER lumen while maintaining capacity for Golgi retrieval (bikard2019thekdelreceptor pages 1-2).
ERp29 functions as a specialized ER chaperone that assists protein folding through mechanisms independent of disulfide bond catalysis (huang2015erp29attenuatescigarette pages 1-2, adams2021theroleof pages 1-3, sakono2022erendogenousprotein pages 2-4). The N-terminal thioredoxin-like domain binds misfolded or partially folded proteins, preventing aggregation and facilitating productive folding pathways (huang2015erp29attenuatescigarette pages 1-2, sakono2022erendogenousprotein pages 2-4). Multiple studies have demonstrated that ERp29 exhibits chaperone-like properties similar to classical PDIs but operates through non-catalytic mechanisms (adams2021theroleof pages 1-3, powell2021proteindisulphideisomerase pages 3-4, rahman2022functionsandmechanisms pages 1-2).
A defining feature of ERp29 function is its recruitment to the calnexin (CNX) and calreticulin (CRT) lectin chaperone system (kozlov2017mappingtheer pages 1-3, kozlov2020calnexincycle– pages 1-3, sakono2022erendogenousprotein pages 2-4). In this cycle, newly synthesized N-glycosylated proteins bearing monoglucosylated glycans (Glc₁Man₉GlcNAc₂) bind to CNX or CRT, which in turn recruit ERp29 alongside other folding factors including ERp57 (a protein disulfide isomerase) and cyclophilin B (a peptidyl-prolyl isomerase) (kozlov2020calnexincycle– pages 1-3, suzuki2021foldingandquality pages 1-3). The ERp29 D domain binds directly to the proline-rich P domains of CNX and CRT with micromolar affinity (Kd < 20 μM for CNX and ~13 μM for CRT), forming ternary chaperone-client complexes (kozlov2017mappingtheer pages 3-4, kozlov2017mappingtheer pages 4-5).
Kozlov et al. (2017) elucidated the structural basis of this interaction through crystallographic studies, showing that the tip of the CNX/CRT P domain inserts into a binding groove formed by helices α8 and α9 of the ERp29 D domain (kozlov2017mappingtheer pages 3-4, kozlov2017mappingtheer pages 4-5). A conserved aspartate residue (D348 in CNX, D248 in CRT) forms critical salt bridges with ERp29 R223, and mutation of D348K completely abrogates binding to ERp29, ERp57, and CypB, indicating that this residue serves as a universal binding site for multiple P-domain-recruited chaperones (kozlov2017mappingtheer pages 4-5, kozlov2017mappingtheer pages 5-6). This convergent evolution of binding sites allows CNX and CRT to recruit structurally diverse folding factors through a common P-domain adapter mechanism (kozlov2017mappingtheer pages 1-3, kozlov2017mappingtheer pages 5-6).
ERp29 has been implicated in the folding and secretion of several specific protein substrates:
Thyroglobulin: ERp29 plays a crucial role in thyroglobulin (Tg) biogenesis and secretion, particularly evident in congenital hypothyroid disorders where mutant Tg accumulates in the ER (baryshev2004unfoldedproteinresponse pages 1-2). Baryshev et al. (2004) demonstrated that ERp29 associates with ER-retained mutant thyroglobulin in human congenital hypothyroid goiter and rat non-goitrous congenital hypothyroidism, suggesting its involvement in Tg quality control (baryshev2004unfoldedproteinresponse pages 1-2).
Collagen: ERp29 has been shown to facilitate collagen processing and secretion, working in concert with other ER chaperones to assist the complex folding and assembly of collagen molecules (kozlov2017mappingtheer pages 1-3).
Epithelial Sodium Channel (ENaC): ERp29 regulates ENaC biogenesis by directing the channel to the Golgi via coat protein complex II (COPII) during biogenesis, where it undergoes proteolytic cleavage that increases channel open probability (bikard2019thekdelreceptor pages 1-2). The KEEL motif and interaction with the KDEL-R are essential for this regulatory function (bikard2019thekdelreceptor pages 1-2).
Glycoproteins in the CNX/CRT Cycle: More broadly, ERp29 assists in the folding of glycoproteins that enter the calnexin/calreticulin quality control pathway, acting as an "attachment-enhancing" co-chaperone that stabilizes chaperone-client interactions (kozlov2017mappingtheer pages 1-3, sakono2022erendogenousprotein pages 2-4, mideksa2022acomprehensiveset pages 1-2).
ERp29 is an integral component of the calnexin/calreticulin (CNX/CRT) cycle, a specialized ER quality control system for N-glycosylated proteins (kozlov2020calnexincycle– pages 1-3, suzuki2021foldingandquality pages 1-3). In this pathway, glucosidase I and II sequentially remove glucose residues from the Glc₃Man₉GlcNAc₂ glycan attached to nascent glycoproteins. The monoglucosylated form (Glc₁Man₉GlcNAc₂) specifically binds to CNX or CRT, creating a platform for recruiting ERp29, ERp57, and cyclophilin B (kozlov2020calnexincycle– pages 1-3). After glucosidase II removes the final glucose, properly folded proteins exit the cycle and proceed to the Golgi, while misfolded proteins are reglucosylated by UDP-glucose:glycoprotein glucosyltransferase (UGGT) for additional folding attempts (kozlov2020calnexincycle– pages 1-3, suzuki2021foldingandquality pages 1-3). ERp29's role in this cycle is to enhance chaperone function and client protein folding efficiency without directly catalyzing chemical modifications (kozlov2017mappingtheer pages 1-3, sakono2022erendogenousprotein pages 2-4).
ERp29 is upregulated in response to ER stress and participates in the unfolded protein response (UPR) (huang2015erp29attenuatescigarette pages 1-2, baryshev2004unfoldedproteinresponse pages 1-2). Huang et al. (2015) demonstrated that ERp29 overexpression in retinal pigment epithelial cells increased levels of protective stress response proteins including GRP78, p58IPK, and Nrf2, while reducing pro-apoptotic markers phospho-eIF2α and CHOP (huang2015erp29attenuatescigarette pages 1-2). Conversely, ERp29 knockdown decreased p58IPK and Nrf2 levels, increased p-eIF2α and CHOP, and exacerbated cigarette smoke extract-induced cell death (huang2015erp29attenuatescigarette pages 1-2). These findings indicate that ERp29 attenuates ER stress through modulation of the ATF6-CHOP pathway and regulation of stress sensor proteins (huang2015erp29attenuatescigarette pages 1-2). Baryshev et al. (2004) observed upregulation of ERp29 alongside other ER chaperones (BiP, ERp72, calreticulin, PDI) in thyroid tissues with mutant thyroglobulin accumulation, consistent with activation of the UPR transcriptional arm (baryshev2004unfoldedproteinresponse pages 1-2).
ERp29 regulates protein trafficking through the early secretory pathway via interactions with the COPII coat complex and the KDEL receptor (bikard2019thekdelreceptor pages 1-2). Bikard et al. (2019) showed that depletion of Sec24D, the cargo recognition component of COPII that interacts with ENaC, decreases ENaC functional expression, and that ERp29's KEEL motif is critical for proper ENaC trafficking and maturation (bikard2019thekdelreceptor pages 1-2). The dynamic cycling of ERp29 between the ER and Golgi via KDEL-R allows it to escort client proteins during forward trafficking while maintaining quality control checkpoints (bikard2019thekdelreceptor pages 1-2).
ERp29 participates in ERAD-related quality control decisions, helping to distinguish between foldable and terminally misfolded proteins (suzuki2021foldingandquality pages 1-3, baryshev2004unfoldedproteinresponse pages 1-2). While ERp29 primarily functions to promote protein folding and secretion, it also contributes to the retention of irreparably misfolded proteins in the ER for subsequent degradation (suzuki2021foldingandquality pages 1-3, baryshev2004unfoldedproteinresponse pages 1-2).
Recent work by Cicek et al. (2024) investigated ERp29 as a potential biomarker in idiopathic nonobstructive azoospermia, examining its role as an ER stress-regulated chaperone in male reproductive dysfunction (paskevicius2023calnexinmorethan pages 1-2). This study extends understanding of ERp29's involvement in tissue-specific stress responses.
Lay et al. (2023) demonstrated that ERp29 is secreted from platelets under conditions of ER stress and contributes to platelet ER homeostasis (paskevicius2023calnexinmorethan pages 1-2). Interestingly, He et al. (2024) used knockout mouse models to systematically evaluate PDI family members in venous thrombosis and found that ERp29-deficient mice showed no thrombotic phenotype in the inferior vena cava stenosis model, in contrast to ERp18-deficient mice which exhibited significantly reduced thrombosis (paskevicius2023calnexinmorethan pages 1-2). This suggests functional specialization among PDI family members in hemostatic processes.
Emerging evidence implicates ERp29 in cancer cell survival, drug resistance, and metastasis (yang2022rolesofprotein pages 1-2). Yang et al. (2022) reviewed the role of PDI family proteins in breast cancer, noting that ERp29 upregulates heat shock protein 27 (Hsp27), which confers resistance to doxorubicin-induced apoptosis in breast cancer cells (yang2022rolesofprotein pages 1-2). Multiple 2024 studies have linked ERp29 to epithelial-mesenchymal transition (EMT) regulation and cancer cell migration, suggesting that ERp29 may represent a therapeutic target for highly metastatic cancers (yang2022rolesofprotein pages 1-2).
Sun et al. (2022) provided a comprehensive review of ERp29's role in neurodevelopment, highlighting its contribution to neural cell migration, neuronal morphogenesis, and synaptic function through regulation of ER proteostasis in the developing nervous system (paskevicius2023calnexinmorethan pages 1-2).
Recent structural studies by Paskevicius et al. (2023) and Kozlov et al. (2020) have provided detailed mechanistic insights into ERp29 function within the CNX/CRT system (paskevicius2023calnexinmorethan pages 1-2, kozlov2020calnexincycle– pages 1-3). These studies emphasize ERp29's role as a plurivalent adapter that recruits diverse folding factors to glycoprotein clients through convergent evolution of binding sites on the P domains of lectin chaperones (kozlov2017mappingtheer pages 1-3, kozlov2020calnexincycle– pages 1-3).
Current expert consensus views ERp29 as a specialized, non-catalytic PDI family member that couples client protein folding to lectin-chaperone recruitment and early secretory pathway trafficking (kozlov2017mappingtheer pages 1-3, adams2021theroleof pages 1-3, rahman2022functionsandmechanisms pages 1-2, kozlov2020calnexincycle– pages 1-3). Adams et al. (2021) note that ERp29, along with ERp57 and cyclophilin B, represents one of three known co-chaperones recruited to the CNX/CRT system to promote productive substrate folding (adams2021theroleof pages 1-3). The protein's unique D domain and loss of oxidoreductase activity during evolution suggest functional specialization toward chaperone and trafficking roles rather than disulfide bond catalysis (powell2021proteindisulphideisomerase pages 3-4, rahman2022functionsandmechanisms pages 1-2).
Kozlov and Gehring (2020) emphasize that the calnexin cycle components, including ERp29, reveal common features in how lectin chaperones recruit function-specific chaperones and how quality control mechanisms recognize misfolded proteins (kozlov2020calnexincycle– pages 1-3). The structural diversity of accessory factors binding to the same P-domain site (ERp29, ERp57, CypB) suggests convergent evolution of these chaperones to support glycoprotein folding through complementary mechanisms (kozlov2017mappingtheer pages 1-3, kozlov2017mappingtheer pages 5-6).
ERp29 (UniProt P30040) is a multifunctional ER-resident chaperone that plays critical roles in protein folding, quality control, and trafficking within the early secretory pathway. Distinguished from classical PDI enzymes by its lack of oxidoreductase activity, ERp29 functions primarily as a co-chaperone in the calnexin/calreticulin cycle and as a regulator of protein secretion through interactions with the KDEL receptor and COPII machinery. Its substrate specificity includes thyroglobulin, collagen, ENaC, and glycoproteins entering the CNX/CRT quality control pathway. ERp29 participates in multiple biochemical pathways including the UPR, ERAD, and ER-to-Golgi trafficking, with emerging roles in cancer biology, platelet function, and neurodevelopment. The protein's unique domain architecture and micromolar-affinity binding to CNX/CRT P domains position it as a key adapter molecule coordinating diverse folding factors in ER proteostasis. Recent structural and functional studies from 2020-2024 continue to elucidate ERp29's mechanistic contributions to cellular protein homeostasis and its potential as a therapeutic target in stress-related pathologies.
Key References:
- Kozlov et al. (2017) Structure 25:1415-1422 - Crystal structures of ERp29-P domain complexes (DOI: 10.1016/j.str.2017.07.010)
- Kozlov & Gehring (2020) FEBS J 287:4322-4340 - Calnexin cycle structural review (DOI: 10.1111/febs.15330)
- Bikard et al. (2019) J Biol Chem 294:18324-18336 - KDEL-R role in ENaC trafficking (DOI: 10.1074/jbc.ra119.008331)
- Huang et al. (2015) Invest Ophthalmol Vis Sci 56:6196-6207 - ERp29 in ER stress attenuation (DOI: 10.1167/iovs.15-16795)
- Paskevicius et al. (2023) Cells 12:403 - Calnexin review (DOI: 10.3390/cells12030403)
- Yang et al. (2022) Cancers 14:745 - PDI roles in breast cancer (DOI: 10.3390/cancers14030745)
References
(rahman2022functionsandmechanisms pages 1-2): Nisa Syakila A. Rahman, Syazalina Zahari, Saiful Effendi Syafruddin, Mohd Firdaus-Raih, Teck Yew Low, and M. Aiman Mohtar. Functions and mechanisms of protein disulfide isomerase family in cancer emergence. Cell & Bioscience, Aug 2022. URL: https://doi.org/10.1186/s13578-022-00868-6, doi:10.1186/s13578-022-00868-6. This article has 60 citations and is from a peer-reviewed journal.
(sakono2022erendogenousprotein pages 2-4): Masafumi Sakono. Er endogenous protein complexed with lectin chaperones calnexin/calreticulin. Trends in Glycoscience and Glycotechnology, 34:E69-E73, Jul 2022. URL: https://doi.org/10.4052/tigg.2119.1j, doi:10.4052/tigg.2119.1j. This article has 1 citations and is from a peer-reviewed journal.
(powell2021proteindisulphideisomerase pages 3-4): Lauren E. Powell and Paul A. Foster. Protein disulphide isomerase inhibition as a potential cancer therapeutic strategy. Cancer Medicine, 10:2812-2825, Mar 2021. URL: https://doi.org/10.1002/cam4.3836, doi:10.1002/cam4.3836. This article has 108 citations and is from a peer-reviewed journal.
(huang2015erp29attenuatescigarette pages 1-2): Chuangxin Huang, Joshua J. Wang, Guangjun Jing, Junhua Li, Chenjin Jin, Qiang Yu, Marek W. Falkowski, and Sarah X. Zhang. Erp29 attenuates cigarette smoke extract–induced endoplasmic reticulum stress and mitigates tight junction damage in retinal pigment epithelial cells. Investigative Opthalmology & Visual Science, 56:6196, Oct 2015. URL: https://doi.org/10.1167/iovs.15-16795, doi:10.1167/iovs.15-16795. This article has 51 citations.
(bikard2019thekdelreceptor pages 1-2): Yann Bikard, Jeffrey Viviano, Melissa N. Orr, Lauren Brown, Margaret Brecker, Jonathan Litvak Jeger, Daniel Grits, Laurence Suaud, and Ronald C. Rubenstein. The kdel receptor has a role in the biogenesis and trafficking of the epithelial sodium channel (enac). Journal of Biological Chemistry, 294:18324-18336, Nov 2019. URL: https://doi.org/10.1074/jbc.ra119.008331, doi:10.1074/jbc.ra119.008331. This article has 16 citations and is from a domain leading peer-reviewed journal.
(kozlov2017mappingtheer pages 1-3): Guennadi Kozlov, Juliana Muñoz-Escobar, Karla Castro, and Kalle Gehring. Mapping the er interactome: the p domains of calnexin and calreticulin as plurivalent adapters for foldases and chaperones. Structure, 25 9:1415-1422.e3, Sep 2017. URL: https://doi.org/10.1016/j.str.2017.07.010, doi:10.1016/j.str.2017.07.010. This article has 63 citations and is from a domain leading peer-reviewed journal.
(kozlov2017mappingtheer pages 4-5): Guennadi Kozlov, Juliana Muñoz-Escobar, Karla Castro, and Kalle Gehring. Mapping the er interactome: the p domains of calnexin and calreticulin as plurivalent adapters for foldases and chaperones. Structure, 25 9:1415-1422.e3, Sep 2017. URL: https://doi.org/10.1016/j.str.2017.07.010, doi:10.1016/j.str.2017.07.010. This article has 63 citations and is from a domain leading peer-reviewed journal.
(kozlov2017mappingtheer pages 5-6): Guennadi Kozlov, Juliana Muñoz-Escobar, Karla Castro, and Kalle Gehring. Mapping the er interactome: the p domains of calnexin and calreticulin as plurivalent adapters for foldases and chaperones. Structure, 25 9:1415-1422.e3, Sep 2017. URL: https://doi.org/10.1016/j.str.2017.07.010, doi:10.1016/j.str.2017.07.010. This article has 63 citations and is from a domain leading peer-reviewed journal.
(adams2021theroleof pages 1-3): Benjamin M. Adams, Nathan P. Canniff, Kevin P. Guay, and Daniel N. Hebert. The role of endoplasmic reticulum chaperones in protein folding and quality control. Progress in molecular and subcellular biology, 59:27-50, Jan 2021. URL: https://doi.org/10.1007/978-3-030-67696-4_3, doi:10.1007/978-3-030-67696-4_3. This article has 47 citations.
(kozlov2020calnexincycle– pages 1-3): Guennadi Kozlov and Kalle Gehring. Calnexin cycle – structural features of the er chaperone system. The FEBS Journal, 287:4322-4340, Apr 2020. URL: https://doi.org/10.1111/febs.15330, doi:10.1111/febs.15330. This article has 234 citations.
(kozlov2017mappingtheer pages 3-4): Guennadi Kozlov, Juliana Muñoz-Escobar, Karla Castro, and Kalle Gehring. Mapping the er interactome: the p domains of calnexin and calreticulin as plurivalent adapters for foldases and chaperones. Structure, 25 9:1415-1422.e3, Sep 2017. URL: https://doi.org/10.1016/j.str.2017.07.010, doi:10.1016/j.str.2017.07.010. This article has 63 citations and is from a domain leading peer-reviewed journal.
(baryshev2004unfoldedproteinresponse pages 1-2): M. Baryshev, E. Sargsyan, G. Wallin, A. Lejnieks, S. Furudate, A. Hishinuma, and S. Mkrtchian. Unfolded protein response is involved in the pathology of human congenital hypothyroid goiter and rat non-goitrous congenital hypothyroidism. Journal of molecular endocrinology, 32 3:903-20, Jun 2004. URL: https://doi.org/10.1677/jme.0.0320903, doi:10.1677/jme.0.0320903. This article has 66 citations and is from a peer-reviewed journal.
(suzuki2021foldingandquality pages 1-3): Tadashi Suzuki and Haruhiko Fujihira. Folding and quality control of glycoproteins. Comprehensive Glycoscience, pages 1-28, Dec 2021. URL: https://doi.org/10.1016/b978-0-12-409547-2.14947-9, doi:10.1016/b978-0-12-409547-2.14947-9. This article has 12 citations.
(mideksa2022acomprehensiveset pages 1-2): Yonatan G. Mideksa, Isabel Aschenbrenner, Anja Fux, Dinah Kaylani, Caroline A.M. Weiß, Tuan-Anh Nguyen, Nina C. Bach, Kathrin Lang, Stephan A. Sieber, and Matthias J. Feige. A comprehensive set of er protein disulfide isomerase family members supports the biogenesis of proinflammatory interleukin 12 family cytokines. Journal of Biological Chemistry, 298:102677, Dec 2022. URL: https://doi.org/10.1016/j.jbc.2022.102677, doi:10.1016/j.jbc.2022.102677. This article has 9 citations and is from a domain leading peer-reviewed journal.
(paskevicius2023calnexinmorethan pages 1-2): Tautvydas Paskevicius, Rabih Abou Farraj, Marek Michalak, and Luis B. Agellon. Calnexin, more than just a molecular chaperone. Cells, 12:403, Jan 2023. URL: https://doi.org/10.3390/cells12030403, doi:10.3390/cells12030403. This article has 74 citations.
(yang2022rolesofprotein pages 1-2): Suhui Yang, Chanel Jackson, Eduard Karapetyan, Pranabananda Dutta, Dulcie Kermah, Yong Wu, Yanyuan Wu, John Schloss, and Jaydutt V. Vadgama. Roles of protein disulfide isomerase in breast cancer. Cancers, 14:745, Jan 2022. URL: https://doi.org/10.3390/cancers14030745, doi:10.3390/cancers14030745. This article has 33 citations.